ARTICLE | Distillery Therapeutics
A mAb blocking IL-1 co-receptor for inflammatory, autoimmune diseases
September 12, 2019 9:33 PM UTC
INDICATION: Inflammation; allergy; psoriasis...
BCIQ Company Profiles
INDICATION: Inflammation; allergy; psoriasis...
BCIQ Company Profiles